OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical and practical considerations in the pharmacologic management of narcolepsy
Michael J. Thorpy, Yves Dauvilliers
Sleep Medicine (2014) Vol. 16, Iss. 1, pp. 9-18
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
Michael J. Thorpy, Colin M. Shapiro, Geert Mayer, et al.
Annals of Neurology (2019) Vol. 85, Iss. 3, pp. 359-370
Open Access | Times Cited: 296

Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
Yves Dauvilliers, Isabelle Arnulf, Zoltán Szakács, et al.
SLEEP (2019) Vol. 42, Iss. 11
Open Access | Times Cited: 230

Pitolisant: A Review in Narcolepsy with or without Cataplexy
Yvette N. Lamb
CNS Drugs (2020) Vol. 34, Iss. 2, pp. 207-218
Closed Access | Times Cited: 201

Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy
Hélène A. Emsellem, Michael J. Thorpy, Gert Jan Lammers, et al.
Sleep Medicine (2019) Vol. 67, pp. 128-136
Closed Access | Times Cited: 186

A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
Lawrence P. Carter, Jack E. Henningfield, Y Grace Wang, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 12, pp. 1351-1361
Open Access | Times Cited: 179

Adenosine, caffeine, and sleep–wake regulation: state of the science and perspectives
Carolin Reichert, Tom Deboer, Hans‐Peter Landolt
Journal of Sleep Research (2022) Vol. 31, Iss. 4
Open Access | Times Cited: 82

Treatment Options for Narcolepsy
Lucie Barateau, Régis Lopez, Yves Dauvilliers
CNS Drugs (2016) Vol. 30, Iss. 5, pp. 369-379
Closed Access | Times Cited: 93

New developments in the management of narcolepsy
Vivien C. Abad, Christian Guilleminault
Nature and Science of Sleep (2017) Vol. Volume 9, pp. 39-57
Open Access | Times Cited: 91

Narcolepsy: Beyond the Classic Pentad
Anne Marie Morse, Sooyoung Kim, Shelby Freedman Harris, et al.
CNS Drugs (2025)
Open Access | Times Cited: 1

Sodium Oxybate: Practical Considerations and Patient Perspectives
Maggie Lavender, Cécile Martin, Diana C. Anderson
CNS Drugs (2025)
Open Access | Times Cited: 1

Measurement of narcolepsy symptoms
Yves Dauvilliers, S. Béziat, Carole Pesenti, et al.
Neurology (2017) Vol. 88, Iss. 14, pp. 1358-1365
Open Access | Times Cited: 85

Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
Michelle Baladi, Michael J. Forster, Michael B. Gatch, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 366, Iss. 2, pp. 367-376
Open Access | Times Cited: 79

Car Crashes and Central Disorders of Hypersomnolence: A French Study
Fabio Pizza, Isabelle Jaussent, Régis Lopez, et al.
PLoS ONE (2015) Vol. 10, Iss. 6, pp. e0129386-e0129386
Open Access | Times Cited: 75

Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
Chad Ruoff, Todd J. Swick, Robert C. Doekel, et al.
SLEEP (2016) Vol. 39, Iss. 7, pp. 1379-1387
Open Access | Times Cited: 71

Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy
Richard Bogan, Neil T. Feldman, Hélène A. Emsellem, et al.
Sleep Medicine (2015) Vol. 16, Iss. 9, pp. 1102-1108
Open Access | Times Cited: 65

Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
Michael J. Thorpy, Richard Bogan
Sleep Medicine (2019) Vol. 68, pp. 97-109
Closed Access | Times Cited: 64

Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions
Maximiliano Rapanelli, Christopher Pittenger
Neuropharmacology (2015) Vol. 106, pp. 85-90
Closed Access | Times Cited: 63

Impact of Astroglial Connexins on Modafinil Pharmacological Properties
Adeline Duchêne, Magali Perier, Yan Zhao, et al.
SLEEP (2016) Vol. 39, Iss. 6, pp. 1283-1292
Open Access | Times Cited: 57

Depression and Hypersomnia
Régis Lopez, Lucie Barateau, Elisa Evangelista, et al.
Sleep Medicine Clinics (2017) Vol. 12, Iss. 3, pp. 395-405
Closed Access | Times Cited: 57

Challenges in the development of therapeutics for narcolepsy
Sarah Wurts Black, Akihiro Yamanaka, Thomas S. Kilduff
Progress in Neurobiology (2015) Vol. 152, pp. 89-113
Open Access | Times Cited: 50

Effect of psychostimulants on blood pressure profile and endothelial function in narcolepsy
Adriana Bosco, Régis Lopez, Lucie Barateau, et al.
Neurology (2018) Vol. 90, Iss. 6
Closed Access | Times Cited: 47

Page 1 - Next Page

Scroll to top